Will Gardner

Research Scientist

Institute for Health Metrics and Evaluation

Columbia University Vagelos College of Physicians & Surgeons

I’m a researcher on the Global Burden of Disease Study at the Institute for Health Metrics and Evaluation and a medical student at Columbia University. I conduct research in respiratory epidemiology, infectious disease and pandemic preparedness, health systems strengthening, and health metrics.

Download my CV.

Interests

Infectious Disease & Pandemic Preparedness
Health Systems Strengthening
Respiratory Epidemiology
Health Metrics and Statistical Modeling

Education

Doctor of Medicine, expected 2026

Columbia University
MPH in Global Health, 2020

University of Washington
AB in Sociology, 2017

Harvard University

Featured Publications

Pipe and cigar use, lung function decline and clinical outcomes: an analysis of the NHLBI Pooled Cohorts Study

Introduction: Smoked tobacco is a leading risk factor for cardiopulmonary disease. Pipe and cigar use remains common among US adults, …

WM Gardner, PP Balte, CM Eckhardt, JE Morris, SP Bhatt, DJ Couper, ND Freedman, DR Jacobs, R Kalhan, LR Loehr, SJ London, PL Lutsey, JE Schwartz, W White, S Yende, TR Sanchez, EC Oelsner

Pipe and cigar use, lung function decline and clinical outcomes: an analysis of the NHLBI Pooled Cohorts Study

Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023

For more than three decades, the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) has provided a framework to quantify …

GBD 2023 Disease and Injury and Risk Factor Collaborators

Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023

Global, regional, and national stillbirths at 20 weeks' gestation or longer in 204 countries and territories, 1990-2021: findings from the Global Burden of Disease Study 2021

Stillbirth is a devastating and often avoidable adverse pregnancy outcome. Monitoring stillbirth levels and trends-in a comprehensive …

GBD 2021 Global Stillbirths Collaborators

Global, regional, and national stillbirths at 20 weeks' gestation or longer in 204 countries and territories, 1990-2021: findings from the Global Burden of Disease Study 2021

Prevalence, years lived with disability, and trends in anaemia burden by severity and cause, 1990–2021: findings from the Global Burden of Disease Study 2021

Anaemia is a major health problem worldwide. Global estimates of anaemia burden are crucial for developing appropriate interventions to …

WM Gardner, GBD 2021 Anaemia Collaborators, NJ Kassebaum

Prevalence, years lived with disability, and trends in anaemia burden by severity and cause, 1990–2021: findings from the Global Burden of Disease Study 2021

Group B streptococcus infection during pregnancy and infancy: estimates of regional and global burden

Group B streptococcus (GBS) colonisation during pregnancy can lead to invasive GBS disease (iGBS) in infants, including meningitis or …

BP Gonçalves, SR Procter, P Paul, J Chandna, A Lewin, F Seedat, A Koukounari, Z Dangor, S Leahy, S Santhanam, HB John, J Bramugy, A Bardají, A Abubakar, C Nasambu, R Libster, C Yanotti, E Horváth-Puhó, HT Sørensen, D van de Beek, MW Bijlsma, WM Gardner, NJ Kassebaum, C Trotter, Q Bassat, SA Madhi, P Lambach, M Jit, JE Lawn

Group B streptococcus infection during pregnancy and infancy: estimates of regional and global burden

See all publications